chr6-31164789-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_002701.6(POU5F1):​c.895G>C​(p.Glu299Gln) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

POU5F1
NM_002701.6 missense

Scores

1
7
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.15
Variant links:
Genes affected
POU5F1 (HGNC:9221): (POU class 5 homeobox 1) This gene encodes a transcription factor containing a POU homeodomain that plays a key role in embryonic development and stem cell pluripotency. Aberrant expression of this gene in adult tissues is associated with tumorigenesis. This gene can participate in a translocation with the Ewing's sarcoma gene on chromosome 21, which also leads to tumor formation. Alternative splicing, as well as usage of alternative AUG and non-AUG translation initiation codons, results in multiple isoforms. One of the AUG start codons is polymorphic in human populations. Related pseudogenes have been identified on chromosomes 1, 3, 8, 10, and 12. [provided by RefSeq, Oct 2013]
TCF19 (HGNC:11629): (transcription factor 19) This gene encodes a protein that contains a PHD-type zinc finger domain and likely functions as a transcription factor. The encoded protein plays a role proliferation and apoptosis of pancreatic beta cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.32021773).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
POU5F1NM_002701.6 linkuse as main transcriptc.895G>C p.Glu299Gln missense_variant 5/5 ENST00000259915.13
POU5F1NM_001173531.3 linkuse as main transcriptc.385G>C p.Glu129Gln missense_variant 5/5
POU5F1NM_203289.6 linkuse as main transcriptc.385G>C p.Glu129Gln missense_variant 4/4
POU5F1NM_001285986.2 linkuse as main transcriptc.307G>C p.Glu103Gln missense_variant 3/3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
POU5F1ENST00000259915.13 linkuse as main transcriptc.895G>C p.Glu299Gln missense_variant 5/51 NM_002701.6 P1Q01860-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
96
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 12, 2022The c.385G>C (p.E129Q) alteration is located in exon 4 (coding exon 4) of the POU5F1 gene. This alteration results from a G to C substitution at nucleotide position 385, causing the glutamic acid (E) at amino acid position 129 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.024
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.16
T;T;T;.;T;T;T
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.88
.;.;.;D;.;D;D
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.32
T;T;T;T;T;T;T
MetaSVM
Uncertain
0.16
D
MutationAssessor
Uncertain
2.1
M;.;.;.;.;.;.
MutationTaster
Benign
0.89
D;D;D;D
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-1.1
N;N;N;.;N;.;.
REVEL
Benign
0.28
Sift
Benign
0.13
T;T;T;.;T;.;.
Sift4G
Benign
0.24
T;T;T;T;T;T;T
Polyphen
0.81
P;.;.;.;.;.;.
Vest4
0.097
MutPred
0.18
Loss of glycosylation at S303 (P = 0.1237);.;.;.;.;.;.;
MVP
0.71
MPC
2.0
ClinPred
0.67
D
GERP RS
5.8
Varity_R
0.13
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr6-31132566; API